Clinical trials
Insulin Resistance trials in the Netherlands with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
72 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 60 |
| Unknown status | 6 |
| Recruiting | 4 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 39 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 8 |
| Amsterdam UMC, location VUmc | 5 |
| Maastricht University | 3 |
| Radboud University Medical Center | 3 |
| TNO | 3 |
| Leiden University Medical Center | 2 |
| Medical Center Alkmaar | 2 |
| German Diabetes Center | 1 |
| Kim Kamphorst | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 72 |
| Obesity | 22 |
| Diabetes Mellitus, Type 2 | 19 |
| Glucose Intolerance | 10 |
| Overweight | 7 |
| Diabetes Mellitus | 4 |
| Glucose Metabolism Disorders | 4 |
| Hypertension | 4 |
| Dyslipidemias | 3 |
| Hyperinsulinism | 3 |
Trials
Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.